Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bandera

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
The American Surgeon|June 30, 2010
Role of growth factors in improved skin flap viability caused by phosphodiesterase-5 inhibitorBradley C Bandera, Thach Pham, Crystal Hill-Pryor, et al.
Clinical Breast Cancer|February 22, 2020
Disparities in Risk Reduction Therapy Recommendations for Young Women With Lobular Carcinoma In-SituBradley C Bandera, Amy Voci, Daniel W Nelson, et al.
The American Surgeon|October 23, 2019
Metastatic Medullary Adenocarcinoma to the Liver: 32 Years after Clinical RemissionChristina M Monaco, Erika S Mabes, Elizabeth Rose, et al.
Surgery|December 9, 2017
Pediatric-protocol of multimodal therapy is associated with improved survival in AYAs and adults with rhabdomyosarcomaTrevan D Fischer, Shrawan G Gaitonde, Bradley C Bandera, et al.
MMWR. Morbidity and Mortality Weekly Report|March 4, 2021
SARS-CoV-2 Infection Risk Among Active Duty Military Members Deployed to a Field Hospital - New York City, April 2020Guy T Clifton, Rituparna Pati, Florian Krammer, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
The American Surgeon|June 30, 2010
Role of growth factors in improved skin flap viability caused by phosphodiesterase-5 inhibitorBradley C Bandera, Thach Pham, Crystal Hill-Pryor, et al.
Clinical Breast Cancer|February 22, 2020
Disparities in Risk Reduction Therapy Recommendations for Young Women With Lobular Carcinoma In-SituBradley C Bandera, Amy Voci, Daniel W Nelson, et al.
The American Surgeon|October 23, 2019
Metastatic Medullary Adenocarcinoma to the Liver: 32 Years after Clinical RemissionChristina M Monaco, Erika S Mabes, Elizabeth Rose, et al.
Surgery|December 9, 2017
Pediatric-protocol of multimodal therapy is associated with improved survival in AYAs and adults with rhabdomyosarcomaTrevan D Fischer, Shrawan G Gaitonde, Bradley C Bandera, et al.
MMWR. Morbidity and Mortality Weekly Report|March 4, 2021
SARS-CoV-2 Infection Risk Among Active Duty Military Members Deployed to a Field Hospital - New York City, April 2020Guy T Clifton, Rituparna Pati, Florian Krammer, et al.
Pageof 2